1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA EHMT2 CTRPv2 pan-cancer AAC 0.18 7e-08
mRNA GRM4 CTRPv2 pan-cancer AAC 0.17 7e-08
mRNA RNF138 CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA HDAC2 CTRPv2 pan-cancer AAC 0.17 7e-08
mRNA KAT6A CTRPv2 pan-cancer AAC 0.18 7e-08
mRNA ZBTB12 CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA CTD-2583A14.9 CTRPv2 pan-cancer AAC 0.18 7e-08
mRNA MYT1L CTRPv2 pan-cancer AAC 0.18 7e-08
mRNA ETF1 CTRPv2 pan-cancer AAC -0.17 7e-08
mRNA PRR12 CTRPv2 pan-cancer AAC 0.17 7e-08
Download CSV